{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:16:35Z","timestamp":1788945395699,"version":"build-2803163510"},"reference-count":29,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM008616; T32AR007080; K24 AR053120"],"award-info":[{"award-number":["T32GM008616; T32AR007080; K24 AR053120"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council of Taiwan","doi-asserted-by":"publisher","award":["104-2314-B-182A-047"],"award-info":[{"award-number":["104-2314-B-182A-047"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3E1961;CORPG3E0143;CORPG3G0231;CMRPG3F0833;CMRPG3F2141;CMRPG3G1401"],"award-info":[{"award-number":["CMRPG3E1961;CORPG3E0143;CORPG3G0231;CMRPG3F0833;CMRPG3F2141;CMRPG3G1401"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chang Gung Memorial Hospital-University of Michigan Medical School","award":["CORPG3G0111;CORPG3G0161;CORPG3H0071"],"award-info":[{"award-number":["CORPG3G0111;CORPG3G0161;CORPG3H0071"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Corticosteroids are commonly prescribed for autoimmune conditions, but their impact on preventable hospitalization rates is unclear. This study sought to investigate the effect of corticosteroid use on hospitalization for ambulatory care sensitive conditions among Taiwanese patients with ankylosing spondylitis (AS) or inflammatory bowel disease (IBD). Methods: This was a retrospective cohort study using adults in the Taiwan National Health Insurance Research database receiving a new diagnosis of AS (n = 40,747) or IBD (n = 4290) between January 2002 and June 2013. Our main outcome measure was odds of preventable hospitalization for eight ambulatory care-sensitive conditions defined by the Agency for Healthcare Research and Quality. Results: In the first quarter (three months) following diagnosis, corticosteroid usage was common among patients with AS and IBD (18.5% and 30%, respectively). For every 100 mg increase in corticosteroid dose per quarter, adjusted odds of preventable hospitalization in the following quarter increased by 5.5% for patients with AS (aOR = 1.055, 95% CI 1.037\u20131.074) and 6.4% for those with IBD (aOR = 1.064, 95% CI 1.046\u20131.082). Conclusions: Relatively low doses of corticosteroids significantly increase AS and IBD patients\u2019 short-term odds of hospitalization for ambulatory care-sensitive conditions. As recommended by current clinical guidelines, physicians should use corticosteroids sparingly in these populations, and prioritize initiation\/escalation of disease-modifying anti-rheumatic drugs for long-term management. If corticosteroids cannot be avoided, patients may require monitoring and\/or prophylaxis for corticosteroid-associated comorbidities (e.g., diabetes) which can result in preventable hospitalizations.<\/jats:p>","DOI":"10.3390\/jcm8050614","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:22:35Z","timestamp":1557400955000},"page":"614","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Cumulative Corticosteroid Dosage on Preventable Hospitalization among Taiwanese Patients with Ankylosing Spondylitis and Inflammatory Bowel Disease"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1802-1427","authenticated-orcid":false,"given":"Beth I.","family":"Wallace","sequence":"first","affiliation":[{"name":"Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI 48105, USA"},{"name":"Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea A.","family":"Harris","sequence":"additional","affiliation":[{"name":"Section of Plastic Surgery, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mochuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Sheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Fu","family":"Kuo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan"},{"name":"Division of Rheumatology, Orthopaedics, and Dermatology, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-3164","authenticated-orcid":false,"given":"Kevin C.","family":"Chung","sequence":"additional","affiliation":[{"name":"Section of Plastic Surgery, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/j.gastro.2013.10.047","article-title":"American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti\u2013TNF-\u03b1 Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn\u2019s Disease","volume":"145","author":"Terdiman","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/acr.22591","article-title":"Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines","volume":"67","author":"Tunnicliffe","year":"2015","journal-title":"Arthritis Care Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/ar592","article-title":"Therapy of ankylosing spondylitis and other spondyloarthritides: Established medical treatment, anti-TNF-\u03b1 therapy and other novel approaches","volume":"4","author":"Braun","year":"2002","journal-title":"Arthritis Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.2003.026799","article-title":"Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study","volume":"53","author":"Card","year":"2004","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.38210","article-title":"Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis","volume":"66","author":"Battafarano","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","article-title":"Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: A nested case-control analysis","volume":"71","author":"Dixon","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ajg.2017.479","article-title":"Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-alpha-Directed Therapy for Inflammatory Bowel Disease","volume":"113","author":"Lewis","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/acr.22642","article-title":"Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis","volume":"68","author":"England","year":"2016","journal-title":"Arthritis Care Res."},{"key":"ref_11","first-page":"1607","article-title":"Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases","volume":"16","author":"Aniwan","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","article-title":"Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: Viewpoints from an EULAR task force","volume":"75","author":"Strehl","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/acr.23185","article-title":"\u201cOfficial View\u201d on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements","volume":"69","author":"Palmowski","year":"2017","journal-title":"Arthritis Care Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0049-0172(99)80003-1","article-title":"Rheumatic diseases in North America\u2019s indigenous peoples","volume":"28","author":"Peschken","year":"1999","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1517\/14740338.2011.560835","article-title":"Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury","volume":"10","author":"Inokuma","year":"2011","journal-title":"Exp. Opin. Drug Saf."},{"key":"ref_17","unstructured":"(2018, July 05). National Health Insurance Research Database, Taiwan. Available online: http:\/\/nhird.nhri.org.tw\/en\/index.htm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1155\/2012\/278495","article-title":"Development and validation of an administrative case definition for inflammatory bowel diseases","volume":"26","author":"Rezaie","year":"2012","journal-title":"Can. J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/art.22682","article-title":"Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases","volume":"57","author":"Singh","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med. Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5217\/ir.2016.14.3.258","article-title":"Change in the diagnosis of inflammatory bowel disease: A hospital-based cohort study from Korea","volume":"14","author":"Lee","year":"2016","journal-title":"Intest. Res."},{"key":"ref_24","first-page":"631","article-title":"FRI0180 Diagnosis journey of patients with ankylosing spondylitis in the united states","volume":"77","author":"Ogdie","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.298.2.187","article-title":"Hydroxychloroquine and Risk of Diabetes in Patients With Rheumatoid Arthritis","volume":"298","author":"Wasko","year":"2007","journal-title":"JAMA."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MLR.0000000000000041","article-title":"Predicting potentially avoidable hospitalizations","volume":"52","author":"Gao","year":"2014","journal-title":"Med. Care"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Waljee, A.K., Wiitala, W.L., Govani, S., Stidham, R., Saini, S., Hou, J., Feagins, L.A., Khan, N., Good, C.B., and Vijan, S. (2016). Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158017"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","article-title":"Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy","volume":"54","author":"Wolfe","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","article-title":"EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases","volume":"72","author":"Duru","year":"2013","journal-title":"Ann. Rheum. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/5\/614\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:49:34Z","timestamp":1760186974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/5\/614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["jcm8050614"],"URL":"https:\/\/doi.org\/10.3390\/jcm8050614","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]}}}